deoxycytidine has been researched along with Carcinoma, Lewis Lung in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 11 (44.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babu, T; Gandin, V; Gibson, D; Ishan, M; Karmakar, S; Nemirovski, A; Yempala, T | 1 |
| Du, B; Lai, J; Lin, M; Wang, Y; Wen, X | 1 |
| Dick, IM; Harken, JA; Khong, A; Lake, RA; Lesterhuis, WJ; Nowak, AK; Robinson, BW; Rozali, EN; Salmons, J | 1 |
| Castiglioni, V; Cesca, M; Decio, A; Giavazzi, R; Rovida, A; Scanziani, E; Scarlato, V | 1 |
| Deshane, JS; Grant, SC; Jin, TH; Ponnazhagan, S; Roth, J; Sawant, A; Schafer, CC; Siegal, GP; Sun, Z; Thannickal, VJ; Tse, HM; Zmijewski, J | 1 |
| Hirano, S; Kuroda, A; Kuwatani, T; Kyogoku, N; Maki, T; Miyauchi, K; Shichinohe, T; Takeuchi, S; Tsuchikawa, T; Wada, M; Yamamura, Y | 1 |
| Bridges, E; Harris, AL | 1 |
| Alrawashdeh, W; Cereser, B; Crnogorac-Jurcevic, T; Demircioglu, F; Elia, G; Ghazaly, E; Hagemann, T; Hodivala-Dilke, KM; Kocher, HM; McDonald, S; Scudamore, CL; Stratford, MR; Wong, PP | 1 |
| Villanueva, MT | 1 |
| Benezra, R; Bertolini, F; Colleoni, M; Daenen, LG; Emmenegger, U; Henke, E; Kerbel, RS; Langenberg, MH; Man, S; Mancuso, P; Roodhart, JM; Shaked, Y; Strieter, RM; Tang, T; Voest, EE; Witte, L; Xu, P; Zhu, Z | 1 |
| Al-Ejeh, F; Brown, MP; Darby, JM | 1 |
| Fushiki, H; Hayakawa, Y; Jiang, J; Kanoh-Azuma, T; Katoh, M; Kawabata, K; Satow, A; Tamai, Y; Tsuchiya, N | 1 |
| Cui, DD; Huang, XB; Huang, Y; Ji, LL; Liu, TG; Mao, SH; Song, HB; Yi, C | 1 |
| Bohnenkamp, H; Bruns, CJ; Dellian, M; Eichhorn, ME; Guenzi, E; Ischenko, I; Jauch, KW; Luedemann, S; Michaelis, U; Papyan, A; Preissler, G; Strieth, S; Werner, A | 1 |
| Abolhassani, M; Baronzio, G; Behzadi, M; Campion, F; Fiorentini, G; Guais, A; Mainini, C; Montagnani, F; Sanders, E; Schwartz, L | 1 |
| Bi, F; Chen, Y; Cheng, K; Ge, J; Gong, FM; Li, Q; Liu, JY; Peng, XC; Qiu, M; Tan, BX; Wei, M; Wu, Y; Xu, F; Zhao, Y; Zhou, Y | 1 |
| Chen, J; Deng, HX; Ding, ZY; Fu, CH; Gao, ZN; He, QM; Kan, B; Li, HL; Li, J; Li, Q; Liu, J; Luo, Y; Mao, YQ; Su, JM; Tan, GH; Tian, L; Wang, L; Wei, YQ; Wen, YJ; Wu, Y; Xiao, F; Xie, XJ; Yang, L; Yi, T; Zhao, X; Zou, CH | 1 |
| Bobek, V; Boubelik, M; Hoffman, RM; Jiang, P; Kolostova, K; Pinterova, D; Plachy, J; Yang, M | 1 |
| Deng, HX; Kan, B; Li, J; Mei, K; Tian, L; Wei, YQ; Wen, YJ | 1 |
| Chen, P; Hou, JM; Li, G; Tian, L; Wei, YQ; Yao, B; Zhang, L; Zhang, R | 1 |
| Deng, HX; Ding, ZY; Hou, JM; Kan, B; Li, J; Li, Q; Liu, JY; Lou, YY; Mao, YQ; Niu, T; Tan, GH; Tian, L; Wei, YQ; Wen, YJ; Wu, Y; Xiao, F; Yang, JL; Yang, L; Zhao, X | 1 |
| Cheng, XC; He, QM; Hou, JM; Hu, B; Jiang, Y; Kan, B; Li, G; Li, J; Tian, L; Wang, L; Wei, YQ; Wen, YJ; Xiao, F; Yao, B; Zhang, L; Zhang, R; Zhao, X; Zhou, Q | 1 |
| Bergman, AM; Kuiper, CM; Peters, GJ; Pinedo, HM; van der Vijgh, WJ; van Moorsel, CJ; Veerman, G; Vermorken, JB | 1 |
| Comijn, EM; Giaccone, G; Lakerveld, B; Peters, GJ; Pinedo, HM; Postmus, PE; Smid, K; Van der Vijgh, WJ; van Moorsel, CJ; Veerman, G; Voorn, DA | 1 |
| Anderson, I; Dang, NH; Elias, A; Herbst, RS; Leong, T; Lynch, C; Salgia, R; Skarin, AT; Strauss, G; Teicher, BA; Vasconcelles, M; Zacarola, P | 1 |
1 trial(s) available for deoxycytidine and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Division; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Mice; Middle Aged; Vinblastine; Vinorelbine | 2001 |
24 other study(ies) available for deoxycytidine and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Expanding the Arsenal of Pt
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbonates; Carcinoma, Lewis Lung; Cell Line, Tumor; Cisplatin; Deoxycytidine; Drug Screening Assays, Antitumor; Estramustine; Female; Gemcitabine; Humans; Ligands; Male; Mice, Inbred C57BL; Organoplatinum Compounds; Paclitaxel; Prodrugs; Prohibitins; Structure-Activity Relationship | 2019 |
Gemcitabine and checkpoint blockade exhibit synergistic anti-tumor effects in a model of murine lung carcinoma.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; B7-H1 Antigen; Carcinoma, Lewis Lung; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Deoxycytidine; Disease Models, Animal; Drug Synergism; Gemcitabine; Immune Checkpoint Inhibitors; Lymphocytes, Tumor-Infiltrating; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Programmed Cell Death 1 Receptor; Tumor Microenvironment; Up-Regulation | 2020 |
Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Lewis Lung; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Deoxycytidine; Drug Synergism; Drug Therapy, Combination; Gemcitabine; Immunity, Innate; Immunologic Factors; Lung Neoplasms; Lymphocyte Depletion; Mesothelioma; Mice; Mice, Transgenic; Neoplasm Transplantation; Survival Analysis; Tumor Burden | 2013 |
Chemotherapy counteracts metastatic dissemination induced by antiangiogenic treatment in mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Movement; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Indoles; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Topotecan | 2013 |
Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways.
Topics: Animals; Carcinoma, Lewis Lung; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Immune Tolerance; Immunosuppressive Agents; Immunotherapy, Adoptive; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred C57BL; Myeloid Cells; Tumor Cells, Cultured; Tumor Microenvironment | 2013 |
The key role of calreticulin in immunomodulation induced by chemotherapeutic agents.
Topics: Animals; Antigens, Surface; Antineoplastic Agents; Apoptosis; Calreticulin; Camptothecin; Carcinoma, Lewis Lung; CD3 Complex; Cell Line, Tumor; Cell Survival; Cisplatin; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Histocompatibility Antigens Class I; Humans; Immunomodulation; Lymphocyte Count; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitomycin; Mitoxantrone; Neoplasm Transplantation; Neoplasms, Experimental; Protein Transport; T-Lymphocytes; Tumor Microenvironment | 2015 |
Vascular-promoting therapy reduced tumor growth and progression by improving chemotherapy efficacy.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Lewis Lung; Deoxycytidine; Gemcitabine; Humans; Pancreatic Neoplasms; Snake Venoms; Verapamil | 2015 |
Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Line, Tumor; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Lung; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreas; Pancreatic Neoplasms; Snake Venoms; Verapamil | 2015 |
Angiogenesis: a sudden rush of blood to the tumour.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Lewis Lung; Deoxycytidine; Humans; Pancreatic Neoplasms; Snake Venoms; Verapamil | 2015 |
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Breast Neoplasms; Carcinoma, Lewis Lung; Cell Proliferation; Chemokine CXCL12; Deoxycytidine; Drug Therapy, Combination; Endothelial Cells; Female; Gemcitabine; Humans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Paclitaxel; Stem Cells; Tumor Burden; Vascular Endothelial Growth Factor A | 2008 |
Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumors.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Carcinoma, Lewis Lung; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Deoxycytidine; Etoposide; Gemcitabine; Heterocyclic Compounds, 1-Ring; Immunohistochemistry; Mice; Mice, Inbred C57BL; Radioimmunotherapy; Ribonucleoproteins; SS-B Antigen | 2009 |
Quantification of mouse pulmonary cancer models by microcomputed tomography imaging.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cisplatin; Deoxycytidine; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Gemcitabine; Genes, ras; Lentivirus; Luciferases; Luminescent Measurements; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Random Allocation; Time Factors; Tumor Suppressor Protein p53; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2009 |
Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Growth Processes; Deoxycytidine; Female; Gemcitabine; Ginsenosides; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Random Allocation; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2009 |
Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cisplatin; Cricetinae; Deoxycytidine; Drug Administration Schedule; Drug Delivery Systems; Gemcitabine; Humans; Immunohistochemistry; Lipopeptides; Liposomes; Lung Neoplasms; Male; Mice; Neovascularization, Pathologic; Paclitaxel; Pancreatic Neoplasms | 2010 |
Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report.
Topics: Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cisplatin; Citrates; Deoxycytidine; Energy Metabolism; Female; Gemcitabine; Humans; Methotrexate; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Pancreatic Neoplasms; Thioctic Acid; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms | 2012 |
Different combination schedules of gemcitabine with endostar affect antitumor efficacy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Lewis Lung; Deoxycytidine; Drug Administration Schedule; Endostatins; Gemcitabine; Mice; Mice, Inbred C57BL; Microvessels; Neovascularization, Pathologic; Recombinant Proteins; Vascular Endothelial Growth Factor A | 2012 |
Induction of apoptosis and tumor regression by vesicular stomatitis virus in the presence of gemcitabine in lung cancer.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Lewis Lung; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; In Vitro Techniques; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Tumor Cells, Cultured; Vesicular stomatitis Indiana virus | 2004 |
Development of a green fluorescent protein metastatic-cancer chick-embryo drug-screen model.
Topics: Animals; Carcinoma, Lewis Lung; Chick Embryo; Deoxycytidine; Disease Models, Animal; Drug Screening Assays, Antitumor; Gemcitabine; Green Fluorescent Proteins; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Streptokinase | 2004 |
[Antitumor effects of interferon-gamma-inducible protein 10 combined with gemcitabine].
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Lewis Lung; Chemokine CXCL10; Chemokines, CXC; Deoxycytidine; Drug Synergism; Escherichia coli; Female; Gemcitabine; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microcirculation; Neovascularization, Pathologic; Plasmids; Transfection | 2005 |
[Effect of full-length cyclin B1 antisense cDNA on chemosensitivity of lewis lung carcinoma cells to gemicitabine in vitro and in vivo].
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Lewis Lung; Cell Cycle; Cyclin B; Cyclin B1; Deoxycytidine; DNA, Antisense; DNA, Complementary; Drug Synergism; Female; Gemcitabine; Mice; Mice, Inbred C57BL; Random Allocation; Ribonucleotide Reductases | 2005 |
Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Carcinoma, Lewis Lung; Deoxycytidine; Drug Administration Schedule; Drug Synergism; Female; Gemcitabine; In Situ Nick-End Labeling; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Quail; Random Allocation; Vaccines, Synthetic; Vascular Endothelial Growth Factor Receptor-2 | 2005 |
Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autoantigens; Carcinoma, Lewis Lung; Cell Line, Tumor; Collagen Type IV; Colonic Neoplasms; Deoxycytidine; Disease Models, Animal; Endothelial Cells; Gemcitabine; Genetic Therapy; Genetic Vectors; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Plasmids; Recombinant Proteins; Treatment Outcome | 2005 |
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Cell Division; Cisplatin; Deoxycytidine; DNA; DNA Adducts; DNA Damage; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluorometry; Gemcitabine; Humans; Intracellular Fluid; Lung Neoplasms; Mice; Ovarian Neoplasms; Platinum; RNA; Time Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1999 |
Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Carcinoma, Lewis Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Kidney; Mice; Mice, Inbred C57BL | 2000 |